prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |review
Virus:
Some antigens are shared between the CAV 1 and 2 by VN.

Pathogenesis and clinical signs:
CAV 2 causes necrosis of the respiratory tract. It is characterised by fever, mild depression and nasal or ocular discharges; corneal opacity is sometimes seen. Animals develop a dry, harsh and persistent cough, with some signs of pneumonia but no hepatitis. Lung lesions may be exacerbated by concurrent bacterial proliferation, e.g. B.bronchiseptica, P.multocida, Streptococci.

Immunity and epidemiology:
Infection spreads readily between unvaccinated dogs, e.g. in stray dog kennels via direct and indirect contact.

Diagnosis:
Virus isolation from respiratory secretions early on in the disease.

Control:
Cross-protection via CAV 1 vaccines. Subcutaneous or intranasal vaccination by tissue-culture attenuated CAV 2 is possible but occasionally results in blue-eye. Isolation of coughing dogs. Disinfection of premises.